Loading...
XSWX
BION
Market cap3.11bUSD
Dec 04, Last price  
45.65CHF
1D
0.44%
1Q
33.28%
Jan 2017
-17.15%
IPO
155.31%
Name

BB Biotech AG

Chart & Performance

D1W1MN
XSWX:BION chart
P/E
32.94
P/S
22.39
EPS
1.39
Div Yield, %
4.38%
Shrs. gr., 5y
-0.21%
Rev. gr., 5y
-30.44%
Revenues
112m
P
332,660,000318,065,000073,820,00054,293,0001,578,000-1,269,000376,820,000937,893,0001,476,387,000659,227,000-796,446,000693,053,000-465,753,000685,238,000699,233,000-396,220,000-351,227,000-199,567,000111,632,000
Net income
76m
P
317,993,000297,395,000-265,411,00045,353,00036,626,000-146,348,000-65,138,000367,834,000931,834,0001,470,139,000652,816,000-802,065,000687,503,000-471,343,000677,431,000691,174,000-404,808,000-357,812,000-206,607,00075,899,000
CFO
305m
+39.53%
-6,141,000-19,804,000201,017,000509,390,000167,838,000-23,411,000169,521,000367,834,000931,834,0001,470,139,000652,816,000-802,065,000687,503,000-471,343,000215,021,000262,449,000-94,787,000-357,812,000218,276,000304,560,000
Dividend
Mar 25, 20242 CHF/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
URL
https://www.bbbiotech.ch/
IPO date
Nov 08, 2006
Employees
10
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT